✦ LIBER ✦

A study of a patient with chronic lymphocytic leukemia (CLL) which demonstrates that proliferation of the lymphocytic clone in CLL does not include T lymphocytes

✍ Scribed by J.T. Prchal; G. Lucivero; A.J. Carroll; A.R. Lawton; C.W. Scott

Book ID: 118373583
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 911 KB
Volume: 13
Category: Article
ISSN: 1090-2341
DOI: 10.1016/0090-1229(79)90067-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abnormal T-cell functions in B-cell chro

Abnormal T-cell functions in B-cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: Report of a case with demonstrated “polyclonality” of T lymphocytes

✍ Giacomo Lucivero; Josef T. Prchal; Alexander R. Lawton; Salvatore Antonaci; Lore 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 568 KB

Consolidation with alemtuzumab in patien

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)

✍ Wendtner, C-M; Ritgen, M; Schweighofer, C D; Fingerle-Rowson, G; Campe, H; Jäger 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

3.12 The Prevalence of Serious Infection

3.12 The Prevalence of Serious Infections in a Community-Based Cohort of Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

✍ Jonathan Moreira; Kari Rabe; James R. Cerhan; John Wilson; Neil Kay; Clive Zent; 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 292 KB

5.30 Preliminary Results from a Phase I/

5.30 Preliminary Results from a Phase I/II Study of Fludarabine (F), Rituximab (R), and Lenalidomide (L) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

✍ Ian W. Flinn; Ines M. Macias-Perez; Patrick S. Tucker; R. Seth Cooper; Habib H. 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 95 KB

Consolidation with alemtuzumab improves

Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

✍ Carmen D. Schweighofer; Matthias Ritgen; Barbara F. Eichhorst; Raymonde Busch; W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Health-Related Quality of Life in Younge

✍ Eichhorst, B. F.; Busch, R.; Obwandner, T.; Kuhn-Hallek, I.; Herschbach, P.; Hal 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 191 KB